How effective is Depakote for Attention Deficit Hyperactivity Disorder? (a real world drug study)
Summary:
Overall ratings: 2.7/5 Long term ratings: 3/5
This is a phase IV clinical study of how effective Depakote (divalproex sodium) is for Attention deficit hyperactivity disorder and for what kind of people. The study is created by eHealthMe from 9 Depakote users and is updated continuously.
What is Depakote?
Depakote has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 55,581 Depakote users. Check the latest studies of Depakote.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 610 drugs and 1,393 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.
9 people are studied for taking Depakote in Attention deficit hyperactivity disorder
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Depakote effectiveness for Attention deficit hyperactivity disorder (number of people):
Overall:
- not at all: 0
- somewhat: 4
- moderate: 4
- high: 1
- very high: 0
Long Term:
- not at all: 0
- somewhat: 1
- moderate: 3
- high: 1
- very high: 0
Gender of people who take Depakote for Attention deficit hyperactivity disorder *:
- female: 22.22 %
- male: 77.78 %
Age of people who take Depakote for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 33.33 %
- 10-19: 55.56 %
- 20-29: 0.0 %
- 30-39: 11.11 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Who find Depakote more effective for Attention Deficit Hyperactivity Disorder?
Gender of people who take Depakote for Attention deficit hyperactivity disorder *:
- female: 0.0 %
- male: 100 %
Age of people who take Depakote for Attention deficit hyperactivity disorder *:
- 0-1: 0.0 %
- 2-9: 100 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Depakote?
- You can start a phase IV clinical trial to monitor Depakote safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Depakote (55,581 reports)
Treatments, associated drugs and conditions:
- Attention deficit hyperactivity disorder (120,330 reports)
How the study uses the data?
The study is based on divalproex sodium (the active ingredients of Depakote) and Depakote (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Estradiol And Norgestimate vs. Natazia, side effect and effectiveness comparison - 6 seconds ago
- Drug interactions of Onglyza and Prilosec Otc - 7 seconds ago
- Could Lipitor cause Idiopathic Or Primary Livedo Reticularis? - 10 seconds ago
- Could Dexmedetomidine cause Diarrhea Aggravated? - 20 seconds ago
- Drug interactions of Lamisil and Carbamazepine - 21 seconds ago
- Could Skyrizi cause Acarodermatitis? - 24 seconds ago
- Tenormin vs. Tiazac, side effect and effectiveness comparison - 41 seconds ago
- Could Cefazolin cause Systemic Inflammatory Response Syndrome? - 42 seconds ago
- Drug interactions of Dexamethasone and Farxiga - 42 seconds ago
- Could Spironolactone cause Insulin Resistance? - a minute ago